Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study-Reference-Cited by-同舟云学术

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

Published:2012-05-02 Issue:sup1 Volume:19 Page:34-36
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Obici Laura¹,Cortese Andrea²,Lozza Alessandro²,Lucchetti J.³,Gobbi Marco³,Palladini Giovanni¹,Perlini Stefano⁴,Saraiva Maria J.⁵,Merlini Giampaolo¹

Affiliation:

1. Amyloid Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy

2. Fondazione IRCCS C. Mondino, Institute of Neurology, University of Pavia, Pavia, Italy

3. Mario Negri Institute for Pharmacological Research, Milan, Italy

4. Department of Medicine, University of Pavia, Pavia, Italy

5. IBMC, Instituto de Biologia Molecular e Celular and ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/13506129.2012.678508

Reference5 articles.

1. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: Long-term follow-up of Japanese patients after liver transplantation

2. Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

3. Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.

4. 4 ′‐iodo‐4′‐Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters

5. Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Caracterización clínica de pacientes con amyloidosis cardíaca en un centro de referencia en Colombia;Archivos de Cardiología de México;2024-08-01

3. Cardiac Amyloidosis: A Comprehensive Review of Pathophysiology, Diagnostic Approach, Applications of Artificial Intelligence, and Management Strategies;Cureus;2024-07-02

4. 2024 Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis;Heart, Lung and Circulation;2024-04

5. The Transthyretin Protein and Amyloidosis – an Extraordinary Chemical Biology Platform;Israel Journal of Chemistry;2024-03-06